Pancreatic Cancer Research

ResearcherYamaguchi UniversityActive in the last 2 years

Shomei Ryozawa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4128-9990; OpenAlex author ID A5065538275. Sources: OpenAlex.

Their work

Papers
11 (first author 3, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
30
Papers, trials and grants by year

2011: 3 papers · 2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 11

  1. Clinical Utility of the Apolipoprotein A2 Isoform Index as a Tumor Marker for Pancreatic Cancer. Last author DOI 10.1002/jgh3.70375↗
  2. The correlation between tumoral CD8 expression and clinical course in patients with unresectable pancreatic cancer using tissue samples acquired by endoscopic … First author DOI 10.1002/jhbp.12072↗
  3. STNM01, the RNA oligonucleotide targeting carbohydrate sulfotransferase 15, as second-line therapy for chemotherapy-refractory patients with unresectable pancr… Co-author DOI 10.1016/j.eclinm.2022.101731↗
  4. Fully covered metal stents vs plastic stents for preoperative biliary drainage in patients with resectable pancreatic cancer without neoadjuvant chemotherapy: … Co-author DOI 10.1002/jhbp.1090↗
  5. Caenorhabditis elegans as a Diagnostic Aid for Pancreatic Cancer. Last author DOI 10.1097/mpa.0000000000001814↗
  6. Choledocho-duodenal Fistula Formation Caused by the Progression of Pancreatic Cancer. First author DOI 10.2169/internalmedicine.5907-20↗
  7. Peroral cholangioscopy-guided probe-based confocal laser endomicroscopy for preoperative diagnosis of pancreatic cancer in a patient with surgically altered an… First author DOI 10.1016/j.vgie.2019.11.011↗
  8. Heat-shock protein 27 plays the key role in gemcitabine-resistance of pancreatic cancer cells. Co-author PMID 22641665↗
  9. Genetic diagnosis of pancreatic cancer using specimens obtained by EUS-FNA. Co-author DOI 10.1111/j.1443-1661.2011.01117.x↗
  10. KNK437 downregulates heat shock protein 27 of pancreatic cancer cells and enhances the cytotoxic effect of gemcitabine. Co-author DOI 10.1159/000321019↗
  11. Proteomic differential display analysis for TS-1-resistant and -sensitive pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectromet… Co-author PMID 21737628↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Akashi Fujita · 4 shared papers, 2020–2025 · strength 0.74
  2. Yuki Tanisaka · 4 shared papers, 2020–2025 · strength 0.74
  3. Hidetoshi Yasuoka · 1 shared paper, 2026 · strength 0.32
  4. Takashi Hoshino · 1 shared paper, 2026 · strength 0.32
  5. Satoru Kakizaki · 1 shared paper, 2026 · strength 0.32
  6. Takao Itoi · 2 shared papers, 2022–2023 · strength 0.30
  7. Masanori Yasuda · 1 shared paper, 2025 · strength 0.27
  8. Toshio Fujisawa · 1 shared paper, 2023 · strength 0.16
  9. Makoto Nishimura · 1 shared paper, 2023 · strength 0.16
  10. Yoko Matsuda · 1 shared paper, 2023 · strength 0.16
  11. Hiroyuki Isayama · 1 shared paper, 2023 · strength 0.16
  12. Motohiko Kato · 1 shared paper, 2023 · strength 0.16
  13. Naohisa Yahagi · 1 shared paper, 2023 · strength 0.16
  14. Kazuki Takakura · 1 shared paper, 2023 · strength 0.16
  15. Tomio Arai · 1 shared paper, 2023 · strength 0.16
  16. Hideyuki Saya · 1 shared paper, 2023 · strength 0.16
  17. Yoshinobu Okabe · 1 shared paper, 2022 · strength 0.14
  18. Koichiro Mandai · 1 shared paper, 2022 · strength 0.14
  19. Takashi Tamura · 1 shared paper, 2022 · strength 0.14
  20. Masanori Kobayashi · 1 shared paper, 2021 · strength 0.13
  21. Kumiko Taba · 4 shared papers, 2011–2012 · strength 0.12
  22. Isao Sakaida · 3 shared papers, 2011–2012 · strength 0.08
  23. Kazuyuki Nakamura · 3 shared papers, 2011–2012 · strength 0.08
  24. Yasuhiro Kuramitsu · 3 shared papers, 2011–2012 · strength 0.08
  25. Manabu Sen-yo · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.